Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > Echelon raises target price from $9.25 to $21.00.

<< Previous

Bullboard Posts

Next >>

Comment by GunnerGon Jul 13, 2020 9:40am

148 Views

Post# 31259593

RE:RE:Echelon raises target price from $9.25 to $21.00.

From the guy who doesn't know when H1 ends or that Q3 and Q4 are in H2.

Newcamo wrote:
thats double but still low 21$ is nothing, what these analysts do is when they want to unload a batch of shares they high target price a stock very high and sell as it rises and when they are interested in a stock , they low ball it and start buying, when they are done, they change their price target to something very high.

realstocky wrote:

They doubled it.... but they say 'dont chase it' , guess what they'll be doing.....

https://www.cantechletter.com/2020/07/dont-chase-liminal-biosciences-says-echelon-wealth/